Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma

Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma

ADP-ribosylation factor (Arf)-GTPase-activating protein (GAP) with coiled-coil, ankyrin repeat and PH domains 1 (ACAP1) has been reported to serve as an adaptor for clathrin coat complex playing a role in endocytic recycling and cellular migration. The potential role of ACAP1 in lung adenocarcinoma...

Full description

Bibliographic Details
Main Authors: Ning Wang, Lingye Zhu, Xiaomei Xu, Chang Yu, Xiaoying Huang
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Computational and Structural Biotechnology Journal
Subjects:
ACAP1
Lung adenocarcinoma
Prognosis
Immune infiltrates
Immunotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2001037022003592

Internet

http://www.sciencedirect.com/science/article/pii/S2001037022003592

Similar Items